Literature DB >> 6180066

Renal filtration, absorption and catabolism of human alpha interferon.

V Bocci, A Pacini, M Muscettola, L Paulesu, G P Pessina, M Santiano, I Viano.   

Abstract

The renal handling of human interferon-alpha has been evaluated by using an isolated and perfused rabbit kidney. IFN-alpha disappears from plasma with a t1/2 of 81 min and the fractional turnover rate is 0.84%/min. About 47 molecules of IFN-alpha are filtrated with 100 molecules of creatinine but most of the IFN is absorbed by tubular cells. This is the first report showing that human IFN-alpha is filtrated by the kidney, largely absorbed, most probably catabolized within tubular epithelium and excreted in negligible amounts with the urine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6180066     DOI: 10.1089/jir.1981.1.347

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  7 in total

Review 1.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Catabolism of interferons.

Authors:  V Bocci
Journal:  Surv Immunol Res       Date:  1982

3.  The pharmacokinetics of peginterferon lambda-1a following single dose administration to subjects with impaired renal function.

Authors:  Matthew W Hruska; Robert Adamczyk; Elizabeth Colston; Michael Hesney; Michele Stonier; Heather Myler; Richard Bertz
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

Review 4.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 5.  Hepatitis C virus infection in nephrology patients.

Authors:  Lionel Rostaing; Jacques Izopet; Nassim Kamar
Journal:  J Nephropathol       Date:  2013-07-01

6.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

7.  Treatment of chronic hepatitis C virus infection in dialysis patients: an update.

Authors:  Hugo Weclawiak; Nassim Kamar; Abdellatif Ould-Mohamed; Isabelle Cardeau-Desangles; Jacques Izopet; Lionel Rostaing
Journal:  Hepat Res Treat       Date:  2010-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.